Nomura Holdings
IONS icon

Nomura Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Nomura Holdings’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.46M Sell
59,400
-36,500
-38% -$2.88M 0.01% 675
2025
Q4 		$7.59M Buy
+95,900
New +$7.22M 0.01% 635
2025
Q3 		– Sell
-30,000
Closed -$1.19M – 1970
2025
Q2 		$1.19M Buy
30,000
+10,000
+50% +$327K ﹤0.01% 955
2025
Q1 		$603K Buy
+20,000
New +$655K ﹤0.01% 1429

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's IONS Position: Q1 2026 in Review

Nomura Holdings reduced its Ionis Pharmaceuticals (IONS) stake by 87% in Q1 2026, selling an estimated $58M and leaving 114,080 shares worth $8.57M. The position accounts for 0.02% of the portfolio, ranked #460.

Nomura Holdings first reported a position in IONS in Q3 2013 and has held it in 38 quarters since. The position peaked at $67.1M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Nomura Holdings held 114,080 shares of Ionis Pharmaceuticals worth $8.57M as of Q1 2026.
  • Nomura Holdings sold 734,735 Ionis Pharmaceuticals shares in Q1 2026, an estimated $58M.
  • Ionis Pharmaceuticals made up 0.02% of Nomura Holdings's portfolio in Q1 2026, its #460 holding.
  • Nomura Holdings first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 38 quarters since.
  • Nomura Holdings's Ionis Pharmaceuticals position peaked at $67.1M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.